Elicio Therapeutics Stock Probability of Future Stock Price Finishing Over 14.04
| ELTX Stock | 4.23 0.24 6.02% |
Elicio |
Elicio Therapeutics Target Price Odds to finish over 14.04
The tendency of Elicio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 14.04 or more in 90 days |
| 4.23 | 90 days | 14.04 | near 1 |
Based on a normal probability distribution, the odds of Elicio Therapeutics to move over 14.04 or more in 90 days from now is near 1 (This Elicio Therapeutics probability density function shows the probability of Elicio Stock to fall within a particular range of prices over 90 days) . Probability of Elicio Therapeutics price to stay between its current price of 4.23 and 14.04 at the end of the 90-day period is about 74.03 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.11 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Elicio Therapeutics will likely underperform. Additionally Elicio Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Elicio Therapeutics Price Density |
| Price |
Predictive Modules for Elicio Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Elicio Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Elicio Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Elicio Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Elicio Therapeutics is not an exception. The market had few large corrections towards the Elicio Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Elicio Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Elicio Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.7 | |
β | Beta against Dow Jones | 2.11 | |
σ | Overall volatility | 1.49 | |
Ir | Information ratio | -0.09 |
Elicio Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Elicio Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Elicio Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Elicio Therapeutics generated a negative expected return over the last 90 days | |
| Elicio Therapeutics has high historical volatility and very poor performance | |
| Elicio Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (35.2 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Elicio Therapeutics generates negative cash flow from operations | |
| About 28.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Elicio Therapeutics CFO Brian Piekos Resigns Amicably - TipRanks |
Elicio Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Elicio Stock often depends not only on the future outlook of the current and potential Elicio Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Elicio Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.1 M | |
| Cash And Short Term Investments | 12.9 M |
Elicio Therapeutics Technical Analysis
Elicio Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Elicio Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Elicio Therapeutics. In general, you should focus on analyzing Elicio Stock price patterns and their correlations with different microeconomic environments and drivers.
Elicio Therapeutics Predictive Forecast Models
Elicio Therapeutics' time-series forecasting models is one of many Elicio Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Elicio Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Elicio Therapeutics
Checking the ongoing alerts about Elicio Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Elicio Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Elicio Therapeutics generated a negative expected return over the last 90 days | |
| Elicio Therapeutics has high historical volatility and very poor performance | |
| Elicio Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (35.2 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Elicio Therapeutics generates negative cash flow from operations | |
| About 28.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Elicio Therapeutics CFO Brian Piekos Resigns Amicably - TipRanks |
Additional Tools for Elicio Stock Analysis
When running Elicio Therapeutics' price analysis, check to measure Elicio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elicio Therapeutics is operating at the current time. Most of Elicio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Elicio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elicio Therapeutics' price. Additionally, you may evaluate how the addition of Elicio Therapeutics to your portfolios can decrease your overall portfolio volatility.